Thompson IM - Search Results

1

Role of 5 alpha-reductase inhibitors in the management of prostate cancer.

Hudak SJ, Hernandez J, Thompson IM. Hudak SJ, et al. Among authors: thompson im. Clin Interv Aging. 2006;1(4):425-31. doi: 10.2147/ciia.2006.1.4.425. Clin Interv Aging. 2006. PMID: 18046919 Free PMC article. Review.

2

The Prostate Cancer Prevention Trial: current status.

Higgins B, Thompson IM. Higgins B, et al. Among authors: thompson im. J Urol. 2004 Feb;171(2 Pt 2):S15-7; discussion S8. doi: 10.1097/01.ju.0000107440.15626.11. J Urol. 2004. PMID: 14713747 Review.

3

What's new in the field of prostate cancer chemoprevention?

Mahal K, Hernandez J, Basler JW, Thompson IM. Mahal K, et al. Among authors: thompson im. Curr Oncol Rep. 2004 May;6(3):237-42. doi: 10.1007/s11912-004-0055-9. Curr Oncol Rep. 2004. PMID: 15066236 Review.

4

The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditions.

Hernandez J, Basler JW, Thompson IM. Hernandez J, et al. Among authors: thompson im. Urol Clin North Am. 2004 May;31(2):213-8. doi: 10.1016/j.ucl.2004.01.009. Urol Clin North Am. 2004. PMID: 15123401 Review.

5

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA Jr. Thompson IM, et al. N Engl J Med. 2004 May 27;350(22):2239-46. doi: 10.1056/NEJMoa031918. N Engl J Med. 2004. PMID: 15163773 Free article. Clinical Trial.

6

Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.

Hernández J, Thompson IM. Hernández J, et al. Among authors: thompson im. Cancer. 2004 Sep 1;101(5):894-904. doi: 10.1002/cncr.20480. Cancer. 2004. PMID: 15329895 Free article. Review.

7

Carcinoma core distribution in patients with palpable and nonpalpable prostate tumors.

Hernandez J, Thompson IM. Hernandez J, et al. Among authors: thompson im. Cancer. 2005 May 1;103(9):1761-2. doi: 10.1002/cncr.21019. Cancer. 2005. PMID: 15742337 Free article. No abstract available.

8

Biomarkers for the detection and prognosis of prostate cancer.

Hernandez J, Canby-Hagino E, Thompson IM. Hernandez J, et al. Among authors: thompson im. Curr Urol Rep. 2005 May;6(3):171-6. doi: 10.1007/s11934-005-0004-7. Curr Urol Rep. 2005. PMID: 15869720 Review.

9

What's new in the field of prostate cancer chemoprevention?

Mahal K, Hernandez J, Basler JW, Thompson IM. Mahal K, et al. Among authors: thompson im. Curr Urol Rep. 2005 May;6(3):177-82. doi: 10.1007/s11934-005-0005-6. Curr Urol Rep. 2005. PMID: 15869721 Review.

10

Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?

Canby-Hagino ED, Swanson GP, Crawford ED, Basler JW, Hernandez J, Thompson IM. Canby-Hagino ED, et al. Among authors: thompson im. Curr Urol Rep. 2005 May;6(3):183-9. doi: 10.1007/s11934-005-0006-5. Curr Urol Rep. 2005. PMID: 15869722 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

855 results

Search Page

Filters